Denali Therapeutics' Series A Round

Denali Therapeutics raised a round of funding on May 14, 2015.

Denali Therapeutics is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinso…

Articles about Denali Therapeutics' Series A Round: